WassimHFaresMD

Critical Care Medicine, Pleural Disease, Pulmonary Vascular Medicine

Assistant Professor, Internal Medicine, Yale University School of Medicine

Dr. Fares is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of North Carolina HospitalsFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2011
St Vincent Charity Medical CenterResidency, Internal Medicine, 2001 - 2004
American University of Beirut Faculty of MedicineClass of 2000

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

PubMed

6 citations
Safety and Feasibility of Obtaining Wedged Pulmonary Artery Samples and Differential Distribution of Biomarkers in Pulmonary Hypertension
Wassim H. Fares, Hubert J. Ford, Andrew J. Ghio, Robert M. Aris
Pulmonary Circulation. 2012-10-01
13 citations
S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertension.
Argyrios Tzouvelekis, Jose D. Herazo-Maya, Changwan Ryu, Jen-Hwa Chu, Yingze Zhang
Respirology. 2018-08-01
19 citations
Right atrial pressure/pulmonary artery wedge pressure ratio: A more specific predictor of survival in pulmonary arterial hypertension.
Wassim H. Fares, Lavanya Bellumkonda, Adriano R. Tonelli, Shannon S. Carson, Paul M. Hassoun
The Journal of Heart and Lung Transplantation. 2016-06-01

First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung DiseaseOctober 31st, 2024